Sfoglia per Autore

opzioni
Mostrati risultati da 1 a 20 di 43
Titolo Data di pubblicazione Autore(i) File
Increased expression of non-functional killer inhibitory receptor CD94 in CD8+ cells of myeloma patients. 2000 BESOSTRI B ;BEGGIATO E ;BIANCHI A ;MARIANI S ;COSCIA M ;PEOLA S ;FOGLIETTA M ;BOCCADORO M ;PILERI A ;MORETTA L ;MASSAIA M
Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion. 2001 MARIANI S; COSCIA M; EVEN J; PEOLA S; FOGLIETTA M; M. BOCCADORO; SBAIZ L; RESTAGNO G; PILERI A; MASSAIA M.
Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapy 2004 COSCIA M; MARIANI S; BATTAGLIO S; DI BELLO C; FIORE F; FOGLIETTA M; PILERI A; BOCCADORO M; MASSAIA M
ROLE OF THE MEVALONATE PATHWAY IN THE IMMUNOMODULATORY ACTIVITY OF ZOLEDRONIC ACID 2004 Pantaleoni F; Mariani S; Muraro M; Peola S; Nuschak B; Foglietta M; Castella B; Fiore F; Coscia M; Boccadoro M; Massaia M
Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells 2005 F. FIORE; B. NUSCHAK; S. PEOLA; S. MARIANI; M. MURARO; M. FOGLIETTA; M. COSCIA; B. BRUNO; M. BOCCADORO; M. MASSAIA
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma 2005 Mariani S; Muraro M; Pantaleoni F; Fiore F; Nuschak B; Peola S; Foglietta M; Palumbo A; Coscia M; Castella B; Bruno B; Bertieri R; Boano L; Boccadoro M; Massaia M
Frequency and function of regulatory T cells (Tregs) are highly preserved in multiple myeloma 2006 Foglietta M; Mariani S; Castella B; Coscia M; Boccadoro M; Massaia M
Distribution of γδ T cells in patients with hematological malignancies 2006 Mariani, S; Pantaleoni, F.; Peola, S.; Hwang, S.Y.; Castella, B.; Matta, G.; Foglietta, M.; Fiore, F.; Coscia, M.A.; Boccadoro, M.; Massaia, M.
Regulatory T Cells (Tregs) Are Highly Preserved in Multiple Myeloma Patients and Can Dominate Effector Functions 2006 Myriam Foglietta; Sara Mariani; Barbara Castella; Marta Coscia; Laura Godio; Serena Zappia; Mario Boccadoro; Massimo Massaia
Enhanced ability of dendritic cells to stimulate innate and adaptive immunity upon short-term incubation with zoledronic acid 2007 FIORE F; CASTELLA B; NUSCHAK B; BERTIERI R; MARIANI S; BRUNO B; PANTALEONI F; FOGLIETTA M; BOCCADORO M; MASSAIA M
Phenotypic and Functional Features of V{gamma}9/V{delta}2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells 2007 Marta Coscia; Silvia Peola; Giorgia Matta; Francesca Pantaleoni; Myriam Foglietta; Daniela Angelini; Sabina Chiaretti; Chiara Riganti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Robin Foà; Luca Battistini; Mario Boccadoro; Jean Jacques Fournie; Massimo Massaia
The metabolism of mevalonate as a signaling pathway influencing tumor-host interactions and disease progression in chronic lymphocytic leukemia (CLL) 2008 M. Coscia; S. Peola; G. Matta; F. Pantaleoni; M. Foglietta; C. Vitale; D. Angelini; S. Chiaretti; C. Riganti; A. Guarini; D. Drandi; M. Ladetto; A. Bosia; R. Foà; L. Battistini; M. Boccadoro; J.J. Fournie; M. Massaia
Comprehensive assessment of the TCRBV repertoire in small T-cell samples by means of an improved and convenient multiplex PCR method 2009 Mariani S; Hwang SY; Foglietta M; Bonello L; Vitale C; Coscia M; Fiore F; Bruno B; Massaia M.
PHENOTYPIC AND FUNCTIONAL FEATURES OF VGAMMA9/VDELTA2 T CELLS CORRELATE WITH THE MUTATIONAL STATUS OF THE TUMOR IMMUNOGLOBULINE AND WITH DISEASE AGGRESSIVENESS IN CHRONIC LYMPHOCYTIC LEUKEMIA 2009 Coscia M.; Peola S.; Pantaleoni F.; Matta G.M.; Foglietta M.; Vitale C.; Angelini D.F.; Chiaretti S.; Riganti C.; Guarini A.; Drandi D.; Ladetto M.; Bosia A.; Foà R.; Battistini L.; Boccadoro M.; Fournie J.J.; Massaia M.
The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status. 2010 Marta Coscia; Candida Vitale; Silvia Peola; Chiara Riganti; Daniela Angelini; Myriam Foglietta; Francesca Pantaleoni; Giorgia Matta; Sabina Chiaretti; Anna Guarini; Daniela Drandi; Marco Ladetto; Amalia Bosia; Luca Battistini; Robin Foà; Mario Boccadoro; Jean-Jacques Fournié; Massimo Massaia
Immune Modulation by Zoledronic Acid in Human Myeloma: An Advantageous Cross Talk between V{gamma}9V{delta}2 T Cells, {alpha}{beta} CD8+ T Cells, Regulatory T Cells, and Dendritic Cells 2011 Castella B; Riganti C; Fiore F; Pantaleoni F; Canepari ME; Peola S; Foglietta M; Palumbo A; Bosia A; Coscia M; Boccadoro M; Massaia M
IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells 2011 Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M.
Serological Proteome Analysis (SERPA) as a tool for the identification of novel tumor antigens in chronic lymphocytic leukemia (CLL) 2012 Valentina Griggio; Michela Capello; Candida Vitale; Federica Linty; Paola Cappello; Giorgia Mandili; Barbara Castella; Myriam Foglietta; Micol Rigoni; Patrizia Sciancalepore; Daniela Drandi; Marina Ruggeri; Paola Omedé; Marco Ladetto; Francesco Novelli; Mario Boccadoro; Massimo Massaia; Marta Coscia
Identification of Novel Tumor-Associated Antigens in Chronic Lymphocytic Leukemia (CLL) by Serological Proteome Analysis (SERPA) 2012 Marta Coscia; Valentina Griggio; Michela Capello; Candida Vitale; Federica Linty; Paola Cappello; Giorgia Mandili; Barbara Castella; Myriam Foglietta; Micol Rigoni; Patrizia Sciancalepore; Marta Robino; Marina Ruggeri; Daniela Drandi; Paola Omedè; Marco Ladetto; Francesco Novelli; Mario Boccadoro; Massimo Massaia
Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells. 2012 Coscia M; Vitale C; Peola S; Foglietta M; Rigoni M; Griggio V; Castella B; Angelini D; Chiaretti S; Riganti C; Guarini A; Drandi D; Ladetto M; Bosia A; Foà R; Battistini L; Boccadoro M; Fournié JJ; Massaia M.
Mostrati risultati da 1 a 20 di 43
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile